This site is intended for healthcare professionals
Follow the latest in healthcare trends and news!

Latest News

Latest drug news
Drug news
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
2 mins
Latest drug news
Drug news
Topline results from phase II PRECEDENT study of dalzanemdor (SAGE 718) in the treatment of mild cognitive impairment in Parkinson’s disease
1 mins
Latest drug news
Drug news
Positive phase III topline results from Study 501 evaluating lumateperone as adjunctive therapy in patients with major depressive disorder
2 mins
Latest drug news
Drug news
FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
1 mins
Latest drug news
Drug news
Imfinzi (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 phase III trial
1 mins
Latest drug news
Drug news
Columvi (glofitamab) + chemotherapy meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in phase III STARGLO study
1 mins
Latest drug news
Drug news
Update on the phase III RAISE trial for intravenous ganaxolone for the treatment of refractory status epilepticus
1 mins
Latest drug news
Drug news
Fabhalta (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy
2 mins
Latest drug news
Drug news
FDA accepts NDA for SH 201 the first palatable oral liquid of the related chemotherapeutic agent, for the treatment of certain forms of leukemia and other cancers
1 mins
Latest drug news
Drug news
Sphere 360 pulse field ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
2 mins
Latest drug news
Drug news
Late-breaking data presented at AAN supporting long-term safety and efficacy of atogepant (Qulipta) for preventive treatment of migraine - AbbVie
2 mins
Latest drug news
Drug news
Latest real-world evidence presented at WCO-IOF-ESCEO assesses how Evenity (romosozumab) can help to close the treatment gap in osteoporosis.- UCB
1 mins
Latest drug news
Drug news
Saruparib shows favorable activity, safety in mutant advanced solid tumors.- AstraZeneca
3 mins
Latest drug news
Drug news
Key milestone is achieved in the development of PAX 101 and an update is provided on potential NDA submission for the treatment of Stage 1 Human African Trypanosomiasis
1 mins
Latest drug news
Drug news
sNDA is filed for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
1 mins

All insights

Woman having Mammogram, breast cancer screening
Article
Breast Cancer 2023 Wrapped
30 mins
Whats on the horizon?
Article
Novartis-sponsored satellite symposium – From Evidence to Action with Elevated Lp(a)
40 mins
Whats on the horizon?
Article
Novartis-sponsored symposium – Inclisiran: emerging evidence for strategies to reach LDL-C targets
20 mins
Whats on the horizon?
Insight
Selecting migraine treatments for your patient – what should you consider?
40 mins
Whats on the horizon?
Insight
Managing migraine over time – are anti-CGRP treatments robust in the long run?
15 mins
Whats on the horizon?
Insight
Anti-CGRP treatments for migraine – are they holding their promise?
20 mins
Trend articles
Insight
Acute hepatic porphyria (AHP): how to diagnose early and ensure timely AHP management
5 mins
Whats on the horizon?
Insight
Clinical value beyond price alone: anti-TNF biosimilars enable early treatment
10 mins
Whats on the horizon?
Insight
Biosimilars: an option to alleviate the heavy burden of immune-mediated inflammatory diseases
10 mins
Whats on the horizon?
Insight
Clinical value beyond price alone: biosimilars improve patient access to treatment
10 mins
Whats on the horizon?
Insight
Long-term topical management of psoriasis: the road ahead
25 mins
Trend articles
Insight
Over the horizon: early stage trials for NASH
10 mins
Trend articles
Insight
Phase II trials and stem cell therapies
10 mins
Trend articles
Insight
The next global epidemic
5 mins
Trend articles
Insight
The latest treatments in NASH
15 mins
Trend articles
Insight
The future of organ transplantation
5 mins
Trend articles
Insight
Complications of stem cell transplants
5 mins
Trend articles
Insight
Challenges in transplant organ rejection
5 mins
Trend articles
Insight
Treating rejection in organ transplants
10 mins
Whats on the horizon?
News
Moderate-to-severe psoriasis: the disease burden and unmet needs in different patient groups
4 mins
Whats on the horizon?
News
Antibody-drug conjugates (ADCs)
5 mins
Whats on the horizon?
News
Cancer immunotherapies
6 mins
Whats on the horizon?
News
Left ventricular assist devices – A viable therapeutic option for heart failure?
7 mins
Whats on the horizon?
News
Improving non-alcoholic steatohepatitis care – is the finishing line in sight?
6 mins
Whats on the horizon?
News
How close are we to a disease-modifying treatment for Alzheimer’s?
8 mins
Whats on the horizon?
Insight
Biologic efficacy for complications associated with moderate-to-severe psoriasis
4 mins
Whats on the horizon?
Insight
Moderate-to-severe psoriasis: treatment for young women
4 mins
Trend articles
Insight
Chronic myelogenous leukaemia: a remarkable success story
4 mins
Trend articles
Insight
Unravelling the microbiome - health through happy communities
2 mins
Trend articles
Insight
Part two | New hopes for treatment in the global obesity epidemic
4 mins
Trend articles
Insight
Inactivity in the elderly increases their cardiovascular risk by 14%
1 mins
Trend articles
Insight
Type 2 diabetes risk may be increased by statin use in susceptible individuals
1 mins
Trend articles
Insight
Will Glucagon-like peptide-1 agonists dominate the Type 2 Diabetes market?
4 mins
Trend articles
Insight
Part Four | Obesity, Type 2 diabetes and cardiovascular disease: Finding the magic bullet
2 mins
Whats on the horizon?
Insight
Focus on Primary Care - helping GPs diagnose, manage and treat urticaria
1 mins
Whats on the horizon?
Insight
Free haemato-oncology report added to AIKN-IFI congresses section
1 mins
Whats on the horizon?
Insight
Latest updates to the Chronic Spontaneous Urticaria Knowledge Centre
1 mins
Trend articles
Insight
Part Three | Next generation obesity therapies
2 mins
Trend articles
Insight
Medical cannabis - a novel approach to pain control
8 mins
Whats on the horizon?
Insight
Immobility and sleep disruption in the ICU - Latest recommendations
1 mins
Whats on the horizon?
Insight
ESOT 2015 speaker slides added to AIKN-IFI
1 mins
Whats on the horizon?
Insight
Prof Vincent interview - Defining the eCASH Concept in PAD Management
1 mins
Whats on the horizon?
Insight
New: Symposium videos & presentations for immunologists, dermatologists and allergists
1 mins
Trend articles
Insight
Appetite and the brain - white matter integrity to blame?
1 mins
Trend articles
Insight
Magnetic nanoparticles could help rejuvenate damaged hearts
1 mins
Trend articles
Insight
Metastatic melanoma: the new immunotherapies
6 mins
Trend articles
Insight
SGLT2 Inhibitors: good news for diabetes
7 mins
Whats on the horizon?
Insight
Long-term disease control in Psoriasis: announcing a new project
1 mins
Trend articles
Insight
Targeted therapies in triple negative breast cancer
4 mins
Trend articles
Insight
Senolytics: an emerging therapeutic for the prevention and treatment of cardiovascular disease
6 mins
Trend articles
Insight
Part One | The effects of obesity and the links to diabetes and cardiovascular disease: now and in the future
2 mins
Trend articles
Insight
Opioids - Over the horizon
2 mins
Trend articles
Insight
From Acne to Immunotherapy: new applications for FMT (Faecal Microbiota Transplantation)
3 mins
Trend articles
Insight
New approaches to anticoagulant therapy
7 mins
Whats on the horizon?
Insight
Neue Informationsmaterialien in deutscher Sprache zum Management von Schmerzen, Agitation und Delir auf der Intensivstation (in Zusammenarbeit mit Orion Pharma)
1 mins
Whats on the horizon?
Insight
Case studies added to Chronic Spontaneous Urticaria (CSU) Knowledge Centre
1 mins
Whats on the horizon?
Insight
Horizons: a series of opinion & insight articles on disruptive healthcare in practice
1 mins
Whats on the horizon?
Insight
Launch of Chronic Spontaneous Urticaria CME activity
1 mins
Trend articles
Insight
New findings may pave the way for novel HIV drugs
1 mins
Whats on the horizon?
Insight
ATS 2015 symposium materials added to COPD Knowledge Centre
1 mins
Trend articles
Insight
Replacement therapies for opioid drugs in pain treatment
2 mins
Whats on the horizon?
Insight
Launch of new Cystic Fibrosis Knowledge Centre
1 mins
Trend articles
Insight
Parkinson's disease: the struggle to control symptoms
5 mins
Trend articles
Insight
Acute myeloid leukaemia: Hope for new treatments
6 mins
Trend articles
Insight
Adoptive T cell therapy, advanced melanoma and survival
1 mins
Trend articles
Insight
An independent review of current treatments for migraine
3 mins
Whats on the horizon?
Insight
Launch of LAL-Deficiency Knowledge Centre
1 mins
Trend articles
Insight
Migraine treatments: On the horizon
1 mins
Whats on the horizon?
Insight
Psoriasis Knowledge Centre relaunches on Medthority.com
1 mins
Whats on the horizon?
Insight
New rare disease platform launched for Hunter Syndrome
1 mins
Trend articles
Insight
Vitamin D in pregnancy - is it any good?
1 mins
Whats on the horizon?
Insight
New type 2 diabetes CME activity now available on Medthority.com
1 mins
Whats on the horizon?
Insight
Accredited CME: The future of urticaria - advances in CSU research - launched to Medthority.com
1 mins
Trend articles
Insight
Close social relationships may slow cognitive decline
1 mins
Trend articles
Insight
Microbiomes: is there nothing that they can't do?
2 mins
Trend articles
Insight
Reformulation of postnatal haemorrhage prophylaxis could save thousands in lower income countries
3 mins
Trend articles
Insight
Senolytics: Can we treat age-related diseases with a single drug
4 mins
Trend articles
Insight
Opioids: the future and challenging the epidemic
2 mins
Whats on the horizon?
Insight
New inflammatory bowel disease (IBD) Knowledge Centre
1 mins
Trend articles
Insight
Opioids: The war on drugs
5 mins
Trend articles
Insight
Targeted therapies in HER2 positive breast cancer
6 mins
Whats on the horizon?
Insight
Atopic Dermatitis Knowledge Centre launched on Medthority.com
1 mins
Whats on the horizon?
Insight
New publication digest and infographic for Cardiologists.
1 mins
Trend articles
Insight
Exciting developments and new approaches in psoriasis
5 mins
Trend articles
Insight
Genetic variation and drug efficacy - could this pave the way for personalised medicines?
1 mins
Trend articles
Insight
Shaken not stirred your bacteriophage cocktail
3 mins
Whats on the horizon?
Insight
WCD 2015 videos added to the Chronic Spontaneous Urticaria (CSU) Knowledge Centre
1 mins
Trend articles
Insight
Breast Cancer- Targeted therapies
2 mins
Whats on the horizon?
Insight
Launch of Oral Anticoagulation Reversal Knowledge Centre
1 mins
Whats on the horizon?
Insight
NEW: Moderate to Severe Asthma Learning Zone launches on Medthority.com
1 mins
Whats on the horizon?
Insight
COPD experts tackle key topics in our latest Q&A
1 mins
Trend articles
Insight
World Congress of Dermatology 2019 - A new ERA for global Dermatology
1 mins
Trend articles
Insight
Nonalcoholic steatohepatitis: the next global epidemic?
5 mins
Trend articles
Insight
Migraine: The forgotten epidemic?
2 mins
Whats on the horizon?
Insight
Launch of new Chronic Lymphocytic Leukaemia CME
1 mins
Trend articles
Insight
Schizophrenia: challenges in a crowded market
8 mins
Trend articles
Insight
Targeted therapies in HER2 negative breast cancer
5 mins
Trend articles
Insight
The way ahead for cystic fibrosis
4 mins
Trend articles
Insight
Japan's aging population and Alzheimer's
1 mins

Biosimilars insights

Whats on the horizon?

Biosimilars: an option to alleviate the heavy burden of immune-mediated inflammatory diseases

Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.

Whats on the horizon?

Clinical value beyond price alone: biosimilars improve patient access to treatment

Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.

Whats on the horizon?

Clinical value beyond price alone: anti-TNF biosimilars enable early treatment

Developed by EPG Health for Medthority in collaboration with Biogen®. This content is intended for healthcare professionals only, and it has been funded and reviewed by Biogen® for scientific accuracy.

Other insights

Pompe vacuoles
Other insights
What is the outlook for Pompe disease management?
3 mins
Pregnant women and doctor
Other insights
Racism in healthcare systems worsens outcomes for Black women
5 mins
Coronavirus virus cell
Other insights
The future of vaccination in a post-COVID-19 world
10 mins
Human viruses
Other insights
Why do we not have vaccines for HIV and hepatitis C? An overview of current challenges
5 mins
Syringe
Other insights
From chickenpox to shingles: The developmental history of herpes zoster vaccines
5 mins
Challenges in the management of painful diabetic peripheral neuropathy
Other insights
Challenges in the management of painful diabetic peripheral neuropathy
10 mins
Psychedelics in psychiatry – a world first in Australia
Other insights
Psychedelics in psychiatry – a world first in Australia
10 mins
Doctor and patient
Other insights
Managing opioid prescribing in the ‘inherited’ patient with pain
10 mins
Ocean underwater view
Other insights
Looking under the surface of clinical trials: Are the findings valid and relevant to your patients?
20 mins
Magnifying glass
Other insights
Interpreting clinical trial results through a frame of reference: Why take the time?
10 mins
Wooden dominoes falling
Other insights
How can flaws in clinical trial design, conduct and reporting impact clinical decision-making?
10 mins
Drug shelves
Other insights
Empty shelves: drug shortages in the UK
5 mins
Antibody drug conjugate in blue with four drug compounds linked to IgG immunoglobulin; ADC in blue against blue background 3d render
Other insights
Innovations in cancer therapy: antibody-drug conjugates
5 mins
Models illustration of drugs intake
Other insights
Chronotherapy: introducing the circadian rhythms into treatment landscapes
9 mins
Persons eye
Other insights
Vision for a better future: lessons from The Lancet Global Health Commission on Global Eye Health
5 mins
“It’s all in your head”: what long-COVID research has taught us about chronic fatigue syndrome
Other insights
“It’s all in your head”: what long-COVID research has taught us about chronic fatigue syndrome
10 mins
Responding to requests for opioid analgesics from patients with chronic pain
Other insights
Responding to requests for opioid analgesics from patients with chronic pain
10 mins
microbiomes and bacteria
Other insights
Is COVID-19 associated with increased risk of herpes zoster?
10 mins
Black stethoscope on LGBT flag background
Other insights
Do HCPs need specific LGBTQ+ training?
10 mins
What is pneumonia? Education and communication between physicians
Other insights
What is pneumonia? Education and communication between physicians
10 mins
Clinician-patient relationship
Other insights
The clinician-patient relationship, online and offline: An opportunity to contribute to improved population health outcomes
10 mins
Abemaciclib
Other insights
Abemaciclib: a newcomer in the treatment of HR+/HER2− early breast cancer
10 mins
3-a gut feeling teaser
Other insights
A Gut Feeling: The Association Between Cancer and the Microbiome
5 mins
Opioid prescribing for chronic noncancer pain in general practice.jpg
Other insights
Opioid prescribing for chronic noncancer pain in general practice
5 mins
Smart watch
Other insights
Can wearables reliably detect signs of atrial fibrillation? FDA says yes to Fitbit
5 mins
Trend articles
Insight
05/02/24

Senolytics: an emerging therapeutic for the prevention and treatment of cardiovascular disease

Senolytics are small molecules under basic research to determine if they can selectively induce death of senescent cells (damaged cells that do not die but persist and become toxic to the cells around them). Cellular senescence has been shown to drive multiple age-related diseases, including idiopathic pulmonary fibrosis (IPF), a chronic, irreversible and progressive disease that results in scarring of the lungs.

  • 6 mins read
See more

Learning Zones

Think Thrombosis
Overview
THINK THROMBOSIS: Individualised care
1 mins
UCB EHSF 2024
Learning Zone Homepage
Advances in HS
30 mins
UCARE Landing page
Learning Zone
All Things Angioedema and Urticaria: Podcasts
30 mins
Shingles (Herpes Zoster)
Learning Zone Homepage
Herpes Zoster Learning Zone
165 mins
3d rendered medically accurate illustration of a womans large intestine
Learning Zone Homepage
Ulcerative colitis Learning Zone
90 mins
Plaque psoriasis
Learning Zone Homepage
Psoriasis Academy
910 mins
Woman blinking
Learning Zone Homepage
Myasthenia Gravis Learning Zone
110 mins
Migraine teaser
Learning Zone Homepage
Anti-CGRP therapies for migraine
85 mins
3D model of the head
Learning Zone Homepage
Growth Hormone Deficiency
150 mins
Alopecia areata learning zone
Learning Zone Homepage
Alopecia areata Learning Zone
60 mins
Type 2 Diabetes Learning Zone teaser tile
Learning Zone Homepage
Weight Management in Type 2 Diabetes
90 mins
Severe Asthma, medically accurate illustration of the bronchi, Banner image
Learning Zone Homepage
Severe Asthma Learning Zone
100 mins
Responding to unmet needs for metastatic castration-resistant prostate cancer
Learning Zone Homepage
mCRPC in focus
110 mins
CMKD, Kidney disease, AI generated image
Learning Zone Homepage
Complement-mediated kidney diseases
205 mins
Pediatric Eosinophilic Esophagitis teaser image
Learning Zone
Type 2 Inflammation in Gastroenterology
160 mins
Paediatric Dermatitis
Learning Zone Homepage
Pediatric Atopic Dermatitis
30 mins
Myocardium Cardiac muscle fibers banner image
Learning Zone Homepage
Pompe Disease: Key findings from WMS 2022
150 mins
Biomarker innovation in Alzheimer’s disease Learning Zone teaser
Learning Zone Homepage
Biomarker innovation in Alzheimer’s disease Learning Zone
60 mins
Doctor holding patient
Learning Zone Homepage
Supportive care in oncology Learning Zone
150 mins
Doctor separates blood and plasma
Learning Zone Homepage
Albumin in fluid management Learning Zone
115 mins
Red blood cells
Learning Zone Homepage
Lipid management in ASCVD
215 mins
Biosimilars retinal disease teaser, eye ball
Learning Zone Homepage
Biosimilars in retinal disease Learning Zone
132 mins
Diagnosing glaucoma
Learning Zone Homepage
Glaucoma Learning Zone
190 mins
Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators
Learning Zone Homepage
Antiplatelet therapy in ACS: Choices and Controversies
270 mins
patient receiving dialysis, hospital image
Learning Zone Homepage
Chronic Kidney Disease Learning Zone
340 mins
Patient with Hidradenitis suppurativa (HS)
Learning Zone Homepage
Hidradenitis suppurativa
220 mins
Chronic Spontaneous Urticaria
Learning Zone Homepage
Chronic Spontaneous Urticaria
1200 mins
Brain nerve cells
Learning Zone Homepage
Multiple Sclerosis (MS) Learning Zone
160 mins
Food Allergy_Selection of foods and allergies
Learning Zone Homepage
Food Allergy Learning Zone
280 mins
Woman with doctor legs crossed
Learning Zone
PARP inhibitor selection in ovarian cancer Learning Zone
340 mins
Lupus teaser
Learning Zone Homepage
Lupus Learning Zone
240 mins
Woman with gut pain
Learning Zone Homepage
Inflammatory Bowel Disease Learning Zone
100 mins
Primary Hyperoxaluria Type 1
Learning Zone Homepage
Diagnosis and management of primary hyperoxaluria type 1
110 mins
PaedDerma_Girl and Doctor TEASER image
Learning Zone Homepage
Improving treatment options for childhood psoriasis
270 mins
CDK 4/6 teaser image
Learning Zone
CDK4/6 inhibitors in breast cancer
199 mins
Osteoarthritis
Learning Zone Homepage
Managing Osteoarthritis-associated Pain
265 mins
Respiratory Care
Learning Zone Homepage
Respiratory Care
530 mins
Biosimilars
Learning Zone Homepage
Optimising anti-TNF treatment using biosimilars
140 mins
Fibrinogen Deficiency
Learning Zone Homepage
Fibrinogen Deficiency in Bleeding Learning Zone
160 mins